Profile - To The Moon

AlphaSpiker

Expect e Unexpected. 没有最高，只有更高

Posts · 853Posts · 853
Following · 0Following · 0
Followers · 0Followers · 0

- AlphaSpikerAlphaSpiker
  ·11-13 14:00
  $YIDU TECH(02158)$ persistent selling running up to results announcement 22 Nov, some people know what is coming?
  99 Comment
  1
  Share
  Report
- AlphaSpikerAlphaSpiker
  ·11-13 09:59
  share price says it all, very bad management
  Yidu Tech Schedules Board Meeting to Review Interim Results
  Yidu Tech Schedules Board Meeting to Review Interim ResultsYidu Tech’s board will meet Nov. 22, 2026, to consider unaudited interim results for the six months ended Sept. 30, 2026.The board will also
  Yidu Tech Schedules Board Meeting to Review Interim Results
  115 Comment
  1
  Share
  Report
- AlphaSpikerAlphaSpiker
  ·10-28
  $Mapletree Ind Tr(ME8U.SI)$ bye bye to all reits, its gonna be disaster now on
  580 Comment
  1
  Share
  Report
- AlphaSpikerAlphaSpiker
  ·05-19
  $SIA(C6L.SI)$ make some money go eat steak
  5.56K 1
  25
  Share
  Report
- AlphaSpikerAlphaSpiker
  ·03-05
  $Beng Kuang(BEZ.SI)$ 60c baby
  3.05K Comment
  1
  Share
  Report
- AlphaSpikerAlphaSpiker
  ·02-13
  $Pinterest, Inc.(PINS)$ bite the dust
  3.56K Comment
  1
  Share
  Report
- AlphaSpikerAlphaSpiker
  ·02-11
  $Sembcorp Ind(U96.SI)$ time to run very soon, watch it
  4.69K 1
  4
  Share
  Report
- AlphaSpikerAlphaSpiker
  ·02-10
  Position early on this big data platform deployed to medical fields. Gonna be BIG
  YIDU TECH (02158) Partners with Tongji Hospital to Tackle AI Diagnosis and Treatment for Gastrointestinal Tumors, Securing a National Key Project
  YIDU TECH (02158), a leading domestic AI healthcare company, has successfully been selected for a national "Unveiling the List and Appointing the Commander" initiative. The project, a multi-modal AI...
  YIDU TECH (02158) Partners with Tongji Hospital to Tackle AI Diagnosis and Treatment for Gastrointestinal Tumors, Securing a National Key Project
  3.44K Comment
  2
  Share
  Report
- AlphaSpikerAlphaSpiker
  ·02-05
  $YZJ Fin Hldg(YF8.SI)$ is this YZJ Fin or YZJ Finished? Bottomless pit
  5.46K 7
  2
  Share
  Report
- AlphaSpikerAlphaSpiker
  ·02-02
  $StarHub(CC3.SI)$ after Singtel will be Starhub to rise [Cool]
  3.29K Comment
  3
  Share
  Report

Most Discussed

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3573008930783156","uuid":"3573008930783156","gmtCreate":1609918719559,"gmtModify":1611748440282,"name":"AlphaSpiker","pinyin":"alphaspiker","introduction":"","introductionEn":"","signature":"Expect e Unexpected. 没有最高，只有更高","avatar":"https://static.tigerbbs.com/7bf4e96af844a7e9da5720d6045b3532","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":311,"headSize":635,"tweetSize":853,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-4","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Tiger Star","description":"Join the tiger community for 2000 days","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.06.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.61%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.11","exceedPercentage":"80.52%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0}],"userBadgeCount":5,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLinkType":null,"redirectLink":null,"redirectLinkValidityFrom":null,"redirectLinkValidityTo":null,"hasAllocated":1,"isWearing":1,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.81%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101,"isScarce":0,"effectEnabled":0,"plateImgUrl":null,"plateColors":null,"validityTo":null,"validityToTimestamp":null,"wearingSort":0},"individualDisplayBadges":null,"crmLevel":12,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":17,"starInvestorFlag":true,"starInvestorOrderShareNum":15,"subscribeStarInvestorNum":2,"ror":-25.21,"winRationPercentage":78.431373,"showRor":true,"investmentPhilosophy":"buy low sell high ","starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":628760714974056,"gmtCreate":1794549616351,"gmtModify":1794549619498,"author":{"id":"3573008930783156","authorId":"3573008930783156","name":"AlphaSpiker","avatar":"https://static.tigerbbs.com/7bf4e96af844a7e9da5720d6045b3532","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573008930783156","authorIdStr":"3573008930783156"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/02158\">$YIDU TECH(02158)$ </a> persistent selling running up to results announcement 22 Nov, some people know what is coming?&nbsp;","listText":"<a href=\"https://ttm.financial/S/02158\">$YIDU TECH(02158)$ </a> persistent selling running up to results announcement 22 Nov, some people know what is coming?&nbsp;","text":"$YIDU TECH(02158)$ persistent selling running up to results announcement 22 Nov, some people know what is coming?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/628760714974056","isVote":1,"tweetType":1,"viewCount":99,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":628701101642720,"gmtCreate":1794535164243,"gmtModify":1794535167310,"author":{"id":"3573008930783156","authorId":"3573008930783156","name":"AlphaSpiker","avatar":"https://static.tigerbbs.com/7bf4e96af844a7e9da5720d6045b3532","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573008930783156","authorIdStr":"3573008930783156"},"themes":[],"title":"","htmlText":"share price says it all, very bad management&nbsp;","listText":"share price says it all, very bad management&nbsp;","text":"share price says it all, very bad management","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/628701101642720","repostId":"2682972307","repostType":2,"repost":{"id":"2682972307","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"pubTimestamp":1794405012,"share":"https://ttm.financial/m/news/2682972307?lang=en_US&edition=fundamental","pubTime":"2026-11-11 21:50","market":"fut","language":"en","title":"Yidu Tech Schedules Board Meeting to Review Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2682972307","media":"Reuters","summary":"Yidu Tech Schedules Board Meeting to Review Interim ResultsYidu Tech’s board will meet Nov. 22, 2026, to consider unaudited interim results for the six months ended Sept. 30, 2026.The board will also ","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/02158\">Yidu Tech</a> Schedules Board Meeting to Review Interim Results\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\">\n<ul>\n<li>\n          Yidu Tech’s board will meet Nov. 22, 2026, to consider unaudited interim results for the six months ended Sept. 30, 2026.\n        </li>\n<li>\n          The board will also consider whether to pay an interim dividend.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/YIDUF\">Yidu Tech Inc.</a> published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261111-12408959), on November 11, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Yidu Tech Schedules Board Meeting to Review Interim Results</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYidu Tech Schedules Board Meeting to Review Interim Results\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-11-11 21:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      <a href=\"https://laohu8.com/S/02158\">Yidu Tech</a> Schedules Board Meeting to Review Interim Results\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\">\n<ul>\n<li>\n          Yidu Tech’s board will meet Nov. 22, 2026, to consider unaudited interim results for the six months ended Sept. 30, 2026.\n        </li>\n<li>\n          The board will also consider whether to pay an interim dividend.\n        </li>\n</ul>\n<br/>\n<br/>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\">\n<p>\n<i>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. <a href=\"https://laohu8.com/S/YIDUF\">Yidu Tech Inc.</a> published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261111-12408959), on November 11, 2026, and is solely responsible for the information contained therein.</span></i>\n</p>\n</div></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK1189":"医疗保健技术","BK1617":"AI医疗","BK1518":"SaaS概念","02158":"医渡科技"},"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261111:nNDL6BNcdM:1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2682972307","content_text":"<a href=\"https://laohu8.com/S/02158\">Yidu Tech</a> Schedules Board Meeting to Review Interim Results\n    \n\n\n          Yidu Tech’s board will meet Nov. 22, 2026, to consider unaudited interim results for the six months ended Sept. 30, 2026.\n        \n\n          The board will also consider whether to pay an interim dividend.\n        \n\n\n\n\n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Yidu Tech Inc. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261111-12408959), on November 11, 2026, and is solely responsible for the information contained therein.","news_type":1,"symbols_score_info":{"02158":0.9}},"isVote":1,"tweetType":1,"viewCount":115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":623125760696512,"gmtCreate":1793155034393,"gmtModify":1793155037318,"author":{"id":"3573008930783156","authorId":"3573008930783156","name":"AlphaSpiker","avatar":"https://static.tigerbbs.com/7bf4e96af844a7e9da5720d6045b3532","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573008930783156","authorIdStr":"3573008930783156"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/ME8U.SI\">$Mapletree Ind Tr(ME8U.SI)$&nbsp;</a> bye bye to all reits, its gonna be disaster now on","listText":"<a href=\"https://ttm.financial/S/ME8U.SI\">$Mapletree Ind Tr(ME8U.SI)$&nbsp;</a> bye bye to all reits, its gonna be disaster now on","text":"$Mapletree Ind Tr(ME8U.SI)$ bye bye to all reits, its gonna be disaster now on","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/623125760696512","isVote":1,"tweetType":1,"viewCount":580,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":565756265575512,"gmtCreate":1779157316340,"gmtModify":1779157577499,"author":{"id":"3573008930783156","authorId":"3573008930783156","name":"AlphaSpiker","avatar":"https://static.tigerbbs.com/7bf4e96af844a7e9da5720d6045b3532","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573008930783156","authorIdStr":"3573008930783156"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/C6L.SI\">$SIA(C6L.SI)$&nbsp;</a>make some money go eat&nbsp;steak","listText":"<a href=\"https://ttm.financial/S/C6L.SI\">$SIA(C6L.SI)$&nbsp;</a>make some money go eat&nbsp;steak","text":"$SIA(C6L.SI)$ make some money go eat steak","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":25,"commentSize":1,"repostSize":14,"link":"https://ttm.financial/post/565756265575512","isVote":1,"tweetType":1,"viewCount":5560,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":539348027040336,"gmtCreate":1772698325153,"gmtModify":1772700836957,"author":{"id":"3573008930783156","authorId":"3573008930783156","name":"AlphaSpiker","avatar":"https://static.tigerbbs.com/7bf4e96af844a7e9da5720d6045b3532","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573008930783156","authorIdStr":"3573008930783156"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/BEZ.SI\">$Beng Kuang(BEZ.SI)$&nbsp;</a> 60c baby","listText":"<a href=\"https://ttm.financial/S/BEZ.SI\">$Beng Kuang(BEZ.SI)$&nbsp;</a> 60c baby","text":"$Beng Kuang(BEZ.SI)$ 60c baby","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/539348027040336","isVote":1,"tweetType":1,"viewCount":3045,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":532350230328528,"gmtCreate":1770989886501,"gmtModify":1770989890071,"author":{"id":"3573008930783156","authorId":"3573008930783156","name":"AlphaSpiker","avatar":"https://static.tigerbbs.com/7bf4e96af844a7e9da5720d6045b3532","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573008930783156","authorIdStr":"3573008930783156"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/PINS\">$Pinterest, Inc.(PINS)$&nbsp;</a> bite the dust&nbsp;","listText":"<a href=\"https://ttm.financial/S/PINS\">$Pinterest, Inc.(PINS)$&nbsp;</a> bite the dust&nbsp;","text":"$Pinterest, Inc.(PINS)$ bite the dust","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/532350230328528","isVote":1,"tweetType":1,"viewCount":3555,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":531516982296952,"gmtCreate":1770786443308,"gmtModify":1770786447011,"author":{"id":"3573008930783156","authorId":"3573008930783156","name":"AlphaSpiker","avatar":"https://static.tigerbbs.com/7bf4e96af844a7e9da5720d6045b3532","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573008930783156","authorIdStr":"3573008930783156"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/U96.SI\">$Sembcorp Ind(U96.SI)$&nbsp;</a> time to run very soon, watch it","listText":"<a href=\"https://ttm.financial/S/U96.SI\">$Sembcorp Ind(U96.SI)$&nbsp;</a> time to run very soon, watch it","text":"$Sembcorp Ind(U96.SI)$ time to run very soon, watch it","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/531516982296952","isVote":1,"tweetType":1,"viewCount":4685,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":531325800981880,"gmtCreate":1770737339222,"gmtModify":1770737343502,"author":{"id":"3573008930783156","authorId":"3573008930783156","name":"AlphaSpiker","avatar":"https://static.tigerbbs.com/7bf4e96af844a7e9da5720d6045b3532","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573008930783156","authorIdStr":"3573008930783156"},"themes":[],"title":"","htmlText":"Position early on this big data platform deployed to medical fields. Gonna be BIG&nbsp;","listText":"Position early on this big data platform deployed to medical fields. Gonna be BIG&nbsp;","text":"Position early on this big data platform deployed to medical fields. Gonna be BIG","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/531325800981880","repostId":"1136451694","repostType":2,"repost":{"id":"1136451694","kind":"news","weMediaInfo":{"introduction":"Global Stock News First-Time Broadcast","home_visible":1,"media_name":"Stock News","id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"pubTimestamp":1770693093,"share":"https://ttm.financial/m/news/1136451694?lang=en_US&edition=fundamental","pubTime":"2026-02-10 11:11","market":"fut","language":"en","title":"YIDU TECH (02158) Partners with Tongji Hospital to Tackle AI Diagnosis and Treatment for Gastrointestinal Tumors, Securing a National Key Project","url":"https://stock-news.laohu8.com/highlight/detail?id=1136451694","media":"Stock News","summary":"YIDU TECH (02158), a leading domestic AI healthcare company, has successfully been selected for a national \"Unveiling the List and Appointing the Commander\" initiative. The project, a multi-modal AI...","content":"<p>YIDU TECH (02158), a leading domestic AI healthcare company, has successfully been selected for a national \"Unveiling the List and Appointing the Commander\" initiative. The project, a multi-modal AI database for gastrointestinal tumor diagnosis and treatment, was jointly submitted with Tongji Hospital affiliated with Huazhong University of Science and Technology. This initiative is part of the Ministry of Industry and Information Technology's 2025 program for innovative artificial intelligence medical devices.</p>\n<p>The project aims to establish a high-quality, standardized data platform encompassing the entire lifecycle of gastrointestinal tumors. Based on this platform, an AI-assisted diagnosis and treatment system will be developed, covering processes from screening and typing to efficacy prediction. The ultimate goal is to enhance the early detection rate and treatment precision for gastrointestinal tumors in China and to promote the translation of these research outcomes into practical applications.</p>\n<p>The national \"Unveiling the List and Appointing the Commander\" mechanism is a major innovation strategy designed to accelerate breakthroughs in key core technologies and facilitate the conversion of scientific and technological achievements. This particular task focuses on selecting teams with strong R&D and clinical translation capabilities to collectively address critical challenges, or \"bottleneck\" problems, in the healthcare sector. Gastrointestinal tumors present a severe clinical challenge in China, characterized by high incidence and mortality rates, low early diagnosis rates, complex choices for personalized treatment plans, and inaccurate prognosis assessments.</p>\n<p>The \"Standardized Multi-modal Artificial Intelligence Database for Gastrointestinal Tumor Diagnosis and Treatment\" project is led by Professor Liao Jiazhi from the Department of Gastroenterology at Tongji Hospital. The core clinical and research team includes Professor Wang Guihua from Gastrointestinal Surgery, Professor Liu Mei from the Department of Gastroenterology, and Professor Chen Yanyan from the Big Data and Artificial Intelligence Office. YIDU TECH will provide comprehensive technical support. The initiative's core involves building a high-quality, standardized multi-modal data foundation to serve as the engine for AI-driven intelligent diagnosis and treatment throughout the entire process.</p>\n<p>The technical core of this project lies in \"multi-modality\" and \"standardization.\" The platform will integrate full-dimensional, full-cycle data, including gastrointestinal endoscopy images, pathological slides, genetic sequencing, and clinical follow-up records. This will create an unprecedented, high-quality, large-scale, and comprehensive data asset library for gastrointestinal tumors, thereby improving the R&D efficiency of medical AI products and technologies in this field.</p>\n<p>Building on this foundation, YIDU TECH and Tongji Hospital will form a deeply integrated \"innovation consortium.\" During the project implementation period, the consortium plans to aggregate and process tens of thousands of high-quality case data points. It will develop AI algorithm models for several key scenarios, including early screening, precise typing, efficacy prediction, and recurrence risk assessment for gastrointestinal tumors, and will promote their transformation into medical device products and clinical applications.</p>\n<p>Furthermore, the collaboration will involve formulating multiple clinical application guidelines and industry standards related to AI diagnosis and treatment for gastrointestinal tumors. Based on actual clinical needs, they will conduct R&D and transformation of AI products for gastrointestinal tumor diagnosis and treatment. The partnership will also focus on cultivating interdisciplinary talent with backgrounds in both clinical medicine and data science. These measures are considered significant for helping China gain a leading position in global technology and rule-making in this field.</p>\n<p>As a pioneer in the AI healthcare sector, YIDU TECH has accumulated extensive experience in data governance, knowledge graphs, and multi-modal analysis. As of September 30, 2025, the company has served 127 renowned medical institutions across China. Its \"AI Medical Brain,\" YiduCore, has processed and analyzed nearly 7 billion authorized medical records, covering a cooperative hospital network of over 10,000 institutions. This provides a solid data foundation and clinical insights for the training, optimization, and real-world application of AI models.</p>\n<p>Industry analysis suggests that this collaboration is a vivid example of an innovative model driven by clinical demand, powered by AI R&D, and characterized by industry-academia-research-application synergy. It is expected to help enhance the overall diagnosis and treatment level for gastrointestinal tumors in China, offering patients more precise, efficient, and accessible medical services, thereby significantly improving their quality of life.</p>\n<p>YIDU TECH stated that the company will continue to promote the deep integration of cutting-edge technology and clinical needs, fully advancing the project's objectives to push gastrointestinal tumor diagnosis and treatment towards greater intelligence. The data governance standards, AI R&D pathways, and clinical application paradigms explored in this project are expected to be replicable and promotable to other major disease areas, contributing to the \"Healthy China 2030\" initiative.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>YIDU TECH (02158) Partners with Tongji Hospital to Tackle AI Diagnosis and Treatment for Gastrointestinal Tumors, Securing a National Key Project</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nYIDU TECH (02158) Partners with Tongji Hospital to Tackle AI Diagnosis and Treatment for Gastrointestinal Tumors, Securing a National Key Project\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-02-10 11:11</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>YIDU TECH (02158), a leading domestic AI healthcare company, has successfully been selected for a national \"Unveiling the List and Appointing the Commander\" initiative. The project, a multi-modal AI database for gastrointestinal tumor diagnosis and treatment, was jointly submitted with Tongji Hospital affiliated with Huazhong University of Science and Technology. This initiative is part of the Ministry of Industry and Information Technology's 2025 program for innovative artificial intelligence medical devices.</p>\n<p>The project aims to establish a high-quality, standardized data platform encompassing the entire lifecycle of gastrointestinal tumors. Based on this platform, an AI-assisted diagnosis and treatment system will be developed, covering processes from screening and typing to efficacy prediction. The ultimate goal is to enhance the early detection rate and treatment precision for gastrointestinal tumors in China and to promote the translation of these research outcomes into practical applications.</p>\n<p>The national \"Unveiling the List and Appointing the Commander\" mechanism is a major innovation strategy designed to accelerate breakthroughs in key core technologies and facilitate the conversion of scientific and technological achievements. This particular task focuses on selecting teams with strong R&D and clinical translation capabilities to collectively address critical challenges, or \"bottleneck\" problems, in the healthcare sector. Gastrointestinal tumors present a severe clinical challenge in China, characterized by high incidence and mortality rates, low early diagnosis rates, complex choices for personalized treatment plans, and inaccurate prognosis assessments.</p>\n<p>The \"Standardized Multi-modal Artificial Intelligence Database for Gastrointestinal Tumor Diagnosis and Treatment\" project is led by Professor Liao Jiazhi from the Department of Gastroenterology at Tongji Hospital. The core clinical and research team includes Professor Wang Guihua from Gastrointestinal Surgery, Professor Liu Mei from the Department of Gastroenterology, and Professor Chen Yanyan from the Big Data and Artificial Intelligence Office. YIDU TECH will provide comprehensive technical support. The initiative's core involves building a high-quality, standardized multi-modal data foundation to serve as the engine for AI-driven intelligent diagnosis and treatment throughout the entire process.</p>\n<p>The technical core of this project lies in \"multi-modality\" and \"standardization.\" The platform will integrate full-dimensional, full-cycle data, including gastrointestinal endoscopy images, pathological slides, genetic sequencing, and clinical follow-up records. This will create an unprecedented, high-quality, large-scale, and comprehensive data asset library for gastrointestinal tumors, thereby improving the R&D efficiency of medical AI products and technologies in this field.</p>\n<p>Building on this foundation, YIDU TECH and Tongji Hospital will form a deeply integrated \"innovation consortium.\" During the project implementation period, the consortium plans to aggregate and process tens of thousands of high-quality case data points. It will develop AI algorithm models for several key scenarios, including early screening, precise typing, efficacy prediction, and recurrence risk assessment for gastrointestinal tumors, and will promote their transformation into medical device products and clinical applications.</p>\n<p>Furthermore, the collaboration will involve formulating multiple clinical application guidelines and industry standards related to AI diagnosis and treatment for gastrointestinal tumors. Based on actual clinical needs, they will conduct R&D and transformation of AI products for gastrointestinal tumor diagnosis and treatment. The partnership will also focus on cultivating interdisciplinary talent with backgrounds in both clinical medicine and data science. These measures are considered significant for helping China gain a leading position in global technology and rule-making in this field.</p>\n<p>As a pioneer in the AI healthcare sector, YIDU TECH has accumulated extensive experience in data governance, knowledge graphs, and multi-modal analysis. As of September 30, 2025, the company has served 127 renowned medical institutions across China. Its \"AI Medical Brain,\" YiduCore, has processed and analyzed nearly 7 billion authorized medical records, covering a cooperative hospital network of over 10,000 institutions. This provides a solid data foundation and clinical insights for the training, optimization, and real-world application of AI models.</p>\n<p>Industry analysis suggests that this collaboration is a vivid example of an innovative model driven by clinical demand, powered by AI R&D, and characterized by industry-academia-research-application synergy. It is expected to help enhance the overall diagnosis and treatment level for gastrointestinal tumors in China, offering patients more precise, efficient, and accessible medical services, thereby significantly improving their quality of life.</p>\n<p>YIDU TECH stated that the company will continue to promote the deep integration of cutting-edge technology and clinical needs, fully advancing the project's objectives to push gastrointestinal tumor diagnosis and treatment towards greater intelligence. The data governance standards, AI R&D pathways, and clinical application paradigms explored in this project are expected to be replicable and promotable to other major disease areas, contributing to the \"Healthy China 2030\" initiative.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK1518":"SaaS概念","BK1617":"AI医疗","02158":"医渡科技","BK1189":"医疗保健技术"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1136451694","content_text":"YIDU TECH (02158), a leading domestic AI healthcare company, has successfully been selected for a national \"Unveiling the List and Appointing the Commander\" initiative. The project, a multi-modal AI database for gastrointestinal tumor diagnosis and treatment, was jointly submitted with Tongji Hospital affiliated with Huazhong University of Science and Technology. This initiative is part of the Ministry of Industry and Information Technology's 2025 program for innovative artificial intelligence medical devices.\nThe project aims to establish a high-quality, standardized data platform encompassing the entire lifecycle of gastrointestinal tumors. Based on this platform, an AI-assisted diagnosis and treatment system will be developed, covering processes from screening and typing to efficacy prediction. The ultimate goal is to enhance the early detection rate and treatment precision for gastrointestinal tumors in China and to promote the translation of these research outcomes into practical applications.\nThe national \"Unveiling the List and Appointing the Commander\" mechanism is a major innovation strategy designed to accelerate breakthroughs in key core technologies and facilitate the conversion of scientific and technological achievements. This particular task focuses on selecting teams with strong R&D and clinical translation capabilities to collectively address critical challenges, or \"bottleneck\" problems, in the healthcare sector. Gastrointestinal tumors present a severe clinical challenge in China, characterized by high incidence and mortality rates, low early diagnosis rates, complex choices for personalized treatment plans, and inaccurate prognosis assessments.\nThe \"Standardized Multi-modal Artificial Intelligence Database for Gastrointestinal Tumor Diagnosis and Treatment\" project is led by Professor Liao Jiazhi from the Department of Gastroenterology at Tongji Hospital. The core clinical and research team includes Professor Wang Guihua from Gastrointestinal Surgery, Professor Liu Mei from the Department of Gastroenterology, and Professor Chen Yanyan from the Big Data and Artificial Intelligence Office. YIDU TECH will provide comprehensive technical support. The initiative's core involves building a high-quality, standardized multi-modal data foundation to serve as the engine for AI-driven intelligent diagnosis and treatment throughout the entire process.\nThe technical core of this project lies in \"multi-modality\" and \"standardization.\" The platform will integrate full-dimensional, full-cycle data, including gastrointestinal endoscopy images, pathological slides, genetic sequencing, and clinical follow-up records. This will create an unprecedented, high-quality, large-scale, and comprehensive data asset library for gastrointestinal tumors, thereby improving the R&D efficiency of medical AI products and technologies in this field.\nBuilding on this foundation, YIDU TECH and Tongji Hospital will form a deeply integrated \"innovation consortium.\" During the project implementation period, the consortium plans to aggregate and process tens of thousands of high-quality case data points. It will develop AI algorithm models for several key scenarios, including early screening, precise typing, efficacy prediction, and recurrence risk assessment for gastrointestinal tumors, and will promote their transformation into medical device products and clinical applications.\nFurthermore, the collaboration will involve formulating multiple clinical application guidelines and industry standards related to AI diagnosis and treatment for gastrointestinal tumors. Based on actual clinical needs, they will conduct R&D and transformation of AI products for gastrointestinal tumor diagnosis and treatment. The partnership will also focus on cultivating interdisciplinary talent with backgrounds in both clinical medicine and data science. These measures are considered significant for helping China gain a leading position in global technology and rule-making in this field.\nAs a pioneer in the AI healthcare sector, YIDU TECH has accumulated extensive experience in data governance, knowledge graphs, and multi-modal analysis. As of September 30, 2025, the company has served 127 renowned medical institutions across China. Its \"AI Medical Brain,\" YiduCore, has processed and analyzed nearly 7 billion authorized medical records, covering a cooperative hospital network of over 10,000 institutions. This provides a solid data foundation and clinical insights for the training, optimization, and real-world application of AI models.\nIndustry analysis suggests that this collaboration is a vivid example of an innovative model driven by clinical demand, powered by AI R&D, and characterized by industry-academia-research-application synergy. It is expected to help enhance the overall diagnosis and treatment level for gastrointestinal tumors in China, offering patients more precise, efficient, and accessible medical services, thereby significantly improving their quality of life.\nYIDU TECH stated that the company will continue to promote the deep integration of cutting-edge technology and clinical needs, fully advancing the project's objectives to push gastrointestinal tumor diagnosis and treatment towards greater intelligence. The data governance standards, AI R&D pathways, and clinical application paradigms explored in this project are expected to be replicable and promotable to other major disease areas, contributing to the \"Healthy China 2030\" initiative.","news_type":1,"symbols_score_info":{"02158":1}},"isVote":1,"tweetType":1,"viewCount":3440,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":529338050741312,"gmtCreate":1770254969919,"gmtModify":1770254973570,"author":{"id":"3573008930783156","authorId":"3573008930783156","name":"AlphaSpiker","avatar":"https://static.tigerbbs.com/7bf4e96af844a7e9da5720d6045b3532","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573008930783156","authorIdStr":"3573008930783156"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/YF8.SI\">$YZJ Fin Hldg(YF8.SI)$&nbsp;</a> is this YZJ Fin or YZJ Finished? Bottomless pit","listText":"<a href=\"https://ttm.financial/S/YF8.SI\">$YZJ Fin Hldg(YF8.SI)$&nbsp;</a> is this YZJ Fin or YZJ Finished? Bottomless pit","text":"$YZJ Fin Hldg(YF8.SI)$ is this YZJ Fin or YZJ Finished? Bottomless pit","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":7,"repostSize":0,"link":"https://ttm.financial/post/529338050741312","isVote":1,"tweetType":1,"viewCount":5461,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4138930352338882","authorId":"4138930352338882","name":"Dude6908","avatar":"https://community-static.tradeup.com/news/4b47b1db89aabd822a5ac004380de180","crmLevel":12,"crmLevelSwitch":1,"idStr":"4138930352338882","authorIdStr":"4138930352338882"},"content":"Liquidity dominance When a few funds control a large percentage of daily volume: • Their sell orders can overwhelm bid depth • Prices fall even without bad fundamentals • Retail investors often panic-sell into thin liquidity This can look like intentional suppression.","text":"Liquidity dominance When a few funds control a large percentage of daily volume: • Their sell orders can overwhelm bid depth • Prices fall even without bad fundamentals • Retail investors often panic-sell into thin liquidity This can look like intentional suppression.","html":"Liquidity dominance When a few funds control a large percentage of daily volume: • Their sell orders can overwhelm bid depth • Prices fall even without bad fundamentals • Retail investors often panic-sell into thin liquidity This can look like intentional suppression."},{"author":{"id":"3579147725811975","authorId":"3579147725811975","name":"mamachu","avatar":"https://static.tigerbbs.com/f846f9c871fbbae87c1f03e22600adb5","crmLevel":12,"crmLevelSwitch":0,"idStr":"3579147725811975","authorIdStr":"3579147725811975"},"content":"Yup, look at the chart, it's all the way down. Very disappointing.","text":"Yup, look at the chart, it's all the way down. Very disappointing.","html":"Yup, look at the chart, it's all the way down. Very disappointing."}],"imageCount":0,"langContent":"EN","totalScore":0},{"id":528303394964360,"gmtCreate":1770002367543,"gmtModify":1770002370670,"author":{"id":"3573008930783156","authorId":"3573008930783156","name":"AlphaSpiker","avatar":"https://static.tigerbbs.com/7bf4e96af844a7e9da5720d6045b3532","crmLevel":12,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3573008930783156","authorIdStr":"3573008930783156"},"themes":[],"title":"","htmlText":"<a href=\"https://ttm.financial/S/CC3.SI\">$StarHub(CC3.SI)$&nbsp;</a> after Singtel will be Starhub to rise&nbsp;[Cool]&nbsp;&nbsp;","listText":"<a href=\"https://ttm.financial/S/CC3.SI\">$StarHub(CC3.SI)$&nbsp;</a> after Singtel will be Starhub to rise&nbsp;[Cool]&nbsp;&nbsp;","text":"$StarHub(CC3.SI)$ after Singtel will be Starhub to rise [Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/528303394964360","isVote":1,"tweetType":1,"viewCount":3287,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}